FarFaR - Pharmacy Repository
University of Belgrade, Faculty of Pharmacy
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Hormonska kontracepcija i hormonska supstituciona terapija

Thumbnail
2010
1445.pdf (279.2Kb)
Authors
Stepanović-Petrović, Radica
Article (Published version)
Metadata
Show full item record
Abstract
Hormonal contraception is the most effective method of fertility control, with possible major and minor side-effects, especially for certain groups of women. The most serious side effects are thromboembolic events. That is why, it should not be prescribed in women aged over 35 years who smoke and have the other cardiovascular risks. In some cases hormonal replacement therapy (HRT) has no alternative with similar effects. But HRT also has risks for venous thromboembolism and breast cancer. So, when there is clear indication for HRT it is necessary to use minimum effective dose of the drug for the shortest period, in order to minimize therapy risks. The patient should be informed about all risks of HRT therapy.
Hormonska kontracepcija (HK) je najefikasniji metod kontrole začeća, ali može biti praćena manjim ili većim neželjenim efektima, posebno u izvesnim rizičnim grupama. Najozbiljniji neželjeni efekti jesu tromboembolijski poremećaji. Zbog toga se HK ne preporučuje ženama iznad 35 godina koje puše ili imaju druge faktore rizika za kardiovaskularna oboljenja. U nekim slučajevima hormonska supstituciona terapija (HST) nema alternativu sa sličnim efektima. Ali i ovi lekovi nose rizik od nastanka tromboze i kancera dojke. Zato, kada postoji jasna indikacija za primenu HST neophodno je primeniti najnižu efikasnu dozu hormona u toku najkraćeg perioda, kako bi se rizici sveli na najmanju moguću meru. Žene treba da budu potpuno informisane o rizicima primene ove terapije.
Keywords:
benefits/risks of hormonal contraception / benefits/risks of hormonal replacement therapy / koristi/rizici hormonske kontracepcije / koristi/rizici hormonske supstitucione terapije
Source:
Arhiv za farmaciju, 2010, 60, 2, 158-167
Publisher:
  • Savez farmaceutskih udruženja Srbije, Beograd

ISSN: 0004-1963

Scopus: 2-s2.0-77954191656
[ Google Scholar ]
URI
https://farfar.pharmacy.bg.ac.rs/handle/123456789/1447
Collections
  • Radovi istraživača / Researchers’ publications
Institution/Community
Pharmacy
TY  - JOUR
AU  - Stepanović-Petrović, Radica
PY  - 2010
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1447
AB  - Hormonal contraception is the most effective method of fertility control, with possible major and minor side-effects, especially for certain groups of women. The most serious side effects are thromboembolic events. That is why, it should not be prescribed in women aged over 35 years who smoke and have the other cardiovascular risks. In some cases hormonal replacement therapy (HRT) has no alternative with similar effects. But HRT also has risks for venous thromboembolism and breast cancer. So, when there is clear indication for HRT it is necessary to use minimum effective dose of the drug for the shortest period, in order to minimize therapy risks. The patient should be informed about all risks of HRT therapy.
AB  - Hormonska kontracepcija (HK) je najefikasniji metod kontrole začeća, ali može biti praćena manjim ili većim neželjenim efektima, posebno u izvesnim rizičnim grupama. Najozbiljniji neželjeni efekti jesu tromboembolijski poremećaji. Zbog toga se HK ne preporučuje ženama iznad 35 godina koje puše ili imaju druge faktore rizika za kardiovaskularna oboljenja. U nekim slučajevima hormonska supstituciona terapija (HST) nema alternativu sa sličnim efektima. Ali i ovi lekovi nose rizik od nastanka tromboze i kancera dojke. Zato, kada postoji jasna indikacija za primenu HST neophodno je primeniti najnižu efikasnu dozu hormona u toku najkraćeg perioda, kako bi se rizici sveli na najmanju moguću meru. Žene treba da budu potpuno informisane o rizicima primene ove terapije.
PB  - Savez farmaceutskih udruženja Srbije, Beograd
T2  - Arhiv za farmaciju
T1  - Hormonska kontracepcija i hormonska supstituciona terapija
VL  - 60
IS  - 2
SP  - 158
EP  - 167
UR  - conv_421
ER  - 
@article{
author = "Stepanović-Petrović, Radica",
year = "2010",
abstract = "Hormonal contraception is the most effective method of fertility control, with possible major and minor side-effects, especially for certain groups of women. The most serious side effects are thromboembolic events. That is why, it should not be prescribed in women aged over 35 years who smoke and have the other cardiovascular risks. In some cases hormonal replacement therapy (HRT) has no alternative with similar effects. But HRT also has risks for venous thromboembolism and breast cancer. So, when there is clear indication for HRT it is necessary to use minimum effective dose of the drug for the shortest period, in order to minimize therapy risks. The patient should be informed about all risks of HRT therapy., Hormonska kontracepcija (HK) je najefikasniji metod kontrole začeća, ali može biti praćena manjim ili većim neželjenim efektima, posebno u izvesnim rizičnim grupama. Najozbiljniji neželjeni efekti jesu tromboembolijski poremećaji. Zbog toga se HK ne preporučuje ženama iznad 35 godina koje puše ili imaju druge faktore rizika za kardiovaskularna oboljenja. U nekim slučajevima hormonska supstituciona terapija (HST) nema alternativu sa sličnim efektima. Ali i ovi lekovi nose rizik od nastanka tromboze i kancera dojke. Zato, kada postoji jasna indikacija za primenu HST neophodno je primeniti najnižu efikasnu dozu hormona u toku najkraćeg perioda, kako bi se rizici sveli na najmanju moguću meru. Žene treba da budu potpuno informisane o rizicima primene ove terapije.",
publisher = "Savez farmaceutskih udruženja Srbije, Beograd",
journal = "Arhiv za farmaciju",
title = "Hormonska kontracepcija i hormonska supstituciona terapija",
volume = "60",
number = "2",
pages = "158-167",
url = "conv_421"
}
Stepanović-Petrović, R.. (2010). Hormonska kontracepcija i hormonska supstituciona terapija. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije, Beograd., 60(2), 158-167.
conv_421
Stepanović-Petrović R. Hormonska kontracepcija i hormonska supstituciona terapija. in Arhiv za farmaciju. 2010;60(2):158-167.
conv_421 .
Stepanović-Petrović, Radica, "Hormonska kontracepcija i hormonska supstituciona terapija" in Arhiv za farmaciju, 60, no. 2 (2010):158-167,
conv_421 .

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceInstitutions/communitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB